A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells

作者:Lameijer Lucien N; Ernst Daniel; Hopkins Samantha L; Meijer Michael S; Askes Sven H C; Le Devedec Sylvia E; Bonnet Sylvestre
来源:Angewandte Chemie - International Edition, 2017, 56(38): 11549-11553.
DOI:10.1002/anie.201703890

摘要

We describe two water-soluble ruthenium complexes, [1]Cl-2 and [2]Cl-2, that photodissociate to release a cytotoxic nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with a low dose (21 Jcm(-2)) of red light in an oxygen-independent manner. Using a specific NAMPT activity assay, up to an 18-fold increase in inhibition potency was measured upon red-light activation of [2]Cl-2, while [1]Cl-2 was thermally unstable. For the first time, the dark and red-light-induced cytotoxicity of these photocaged compounds could be tested under hypoxia (1% O-2). In skin (A431) and lung (A549) cancer cells, a 3- to 4-fold increase in cytotoxicity was found upon red-light irradiation for [2]Cl-2, whether the cells were cultured and irradiated with 1% or 21% O-2. These results demonstrate the potential of photoactivated chemotherapy for hypoxic cancer cells, in which classical photodynamic therapy, which relies on oxygen activation, is poorly efficient.

  • 出版日期2017-9-11